QCM
BIIB icon

Qsemble Capital Management’s Biogen BIIB Stock Holding History

Qsemble Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,909
Closed -$1.75M – 465
2025
Q2 		$1.75M Sell
13,909
-558
-4% -$69.5K 0.17% 179
2025
Q1 		$1.98M Buy
14,467
+11,406
+373% +$1.63M 0.21% 161
2024
Q4 		$468K Buy
3,061
+1,446
+90% +$244K 0.06% 291
2024
Q3 		$313K Buy
+1,615
New +$338K 0.06% 300

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Qsemble Capital Management's BIIB Position: Q3 2025 in Review

Qsemble Capital Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 13,909 shares — an estimated $1.75M sold.

Qsemble Capital Management first reported a position in BIIB in Q3 2024 and held it in 4 quarters. The position peaked at $1.98M in Q1 2025. 907 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Qsemble Capital Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 13,909 Biogen shares in Q3 2025, an estimated $1.75M.
  • Qsemble Capital Management first reported a position in Biogen in Q3 2024 and held it in 4 quarters.
  • Qsemble Capital Management's Biogen position peaked at $1.98M in Q1 2025.
  • 907 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Qsemble Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.